Manufacturer record
Globin Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Globin Pharmaceuticals Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between April 2020 and February 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: G-T554, Calcium & Vitamin D3 Tablets IP (CAL D3M Tablets) (exp Jun 2024). RDTL Guwahati (state lab) found it not of standard quality: Dissolution of Calcium. Listed in the February 2023 alert.
Records by type
3 records linked to Globin Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Calcium & Vitamin D3 Tablets IP (CAL D3M Tablets) | Batch G-T554Mfg Jul 2022 · Exp Jun 2024 | Dissolution of CalciumDissolution | RDTL GuwahatiState lab | Feb 2023 |
| OFLOWIND-OZ (Ofloxacin & Ornidazole Tablets IP) | Batch G-T388Mfg Jul 2021 · Exp Jun 2023 | Dissolution ?(Ofloxacin and Ornidazole)?Dissolution | RDTL GuwahatiState lab | Dec 2022 |
| Primaquine Phosphate Tablets I.P. (PRIMELIFE) | Batch LGT-1739Mfg Jun 2018 · Exp May 2020 | AssayAssay | RDTL GuwahatiState lab | Apr 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.